According to a market report by Lucintel, the future of the global patient-derived xenograft model market looks promising with opportunities in the pharmaceutical & biopharmaceutical company, academic & research institute, and CRO & CDMO markets. The global patient-derived xenograft model market is expected to grow with a CAGR of 9.6% from 2025 to 2031. The major drivers for this market are the increasing demand for personalized cancer research, the rising adoption of preclinical oncology models, and the growing focus on targeted drug development.A more than 150-page report to understand trends, opportunity and forecast in patient-derived xenograft model market to 2031 by tumor type (lung cancer, pancreatic cancer, prostate cancer, breast cancer, and others), model type (mice model and rat model), end use (pharmaceutical & biopharmaceutical companies, academic & research institutes, and CRO’s & CDMO’s), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that, within the tumor type category, breast cancer is expected to witness the highest growth over the forecast period.
Within the end use category, CRO & CDMO is expected to witness the highest growth.
Download sample by clicking on patient-derived xenograft model market
In terms of region, North America is expected to witness the highest growth over the forecast period.
Charles River Laboratories, The Jackson Laboratory, Crown Bioscience, Altogen Labs, Envigo, WuXi AppTec, Oncodesign, Hera Biolabs, XenTech, Abnova Corp. are the major suppliers in the patient-derived xenograft model market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected] to get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1-972-636-5056
Explore Our Latest Publications
Wipes Market
Womens Activewear Market
Yoga Market
Cricket Equipment Market
Exercise Bike Market